EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma
Clinical trial NCT00114738 · COMPLETED
Trial details
- NCT number
- NCT00114738
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-15
- Primary completion
- 2016-08-11
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.